Abstract

Konika Sharma: NO financial relationship with a commercial interest | Mark Schattner: YES financial relationship with a commercial interest;boston scientific:Consulting;Novo Nordisk :Advisory Committees or Review Panels | David Faleck: YES financial relationship with a commercial interest;Kaleido Biosciences:Advisory Committees or Review Panels;AzurRx Biopharma:Advisory Committees or Review Panels;Equillium:Consulting;Mallinckrodt Pharmaceuticals:Advisory Committees or Review Panels | Jinru Shia: YES financial relationship with a commercial interest;Paige AI, Inc.:Consulting | Arnold Markowitz: NO financial relationship with a commercial interest | Hans Gerdes: No Answer.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.